Andrew M. Dahlem

Andrew M. Dahlem Email and Phone Number

Indianapolis, IN, US
Andrew M. Dahlem's Location
Indianapolis, Indiana, United States, United States
Andrew M. Dahlem's Contact Details
About Andrew M. Dahlem

Experienced Vice President Research and Development with a demonstrated history of success in the pharmaceutical industry. Strong scientific and operations professional skilled in Research and Development Strategy, Drug Development, Due Diligence, Portfolio Enablement, Competitive Intelligence, Clinical Trial Design, Toxicology, and Drug Metabolism. Excellent mentor and coach to key talent and strong team building skills. Strong history of success in leading and managing a portfolio of assets from Lead Declaration to Phase 2 clinical outcomes. Active in venture fund collaboration and in external innovation investment decisions.

Andrew M. Dahlem's Current Company Details
Dr. Dahlem Consulting, LLC

Dr. Dahlem Consulting, Llc

View
President
Indianapolis, IN, US
Andrew M. Dahlem Work Experience Details
  • Dr. Dahlem Consulting, Llc
    President
    Dr. Dahlem Consulting, Llc
    Indianapolis, In, Us
  • Syra Health
    Board Member
    Syra Health Oct 2023 - Present
    Carmel, In, Us
  • Gate Neurosciences, Inc.
    Co-Founder And Advisor
    Gate Neurosciences, Inc. Apr 2019 - Present
    Indianapolis, Indiana, Us
    Actively engaged in acquisition and development of novel entities to meet patient needs in neurosciences.
  • Dr. Dahlem Consulting, Llc
    President
    Dr. Dahlem Consulting, Llc May 2018 - Present
  • Indiana University School Of Medicine
    Chief, Division Of Clinical Pharmacology And Senior Research Professor Of Medicine
    Indiana University School Of Medicine Nov 2018 - May 2022
    Indianapolis, In, Us
    Advancing the science of Clinical Pharmacology and providing a home for world class research, world class researchers, and education in drug discovery and development in the largest School of Medicine in the United States at Indiana University.
  • Eli Lilly And Company
    Vice President Of Research Operations And Coo Lilly Research Laboratories (Lrl) And Lrl Europe
    Eli Lilly And Company 2007 - Jan 2018
    Indianapolis, Indiana, Us
    Reports to President of Lilly Research Laboratories. Vice-chair of portfolio management committee responsible for scientific and technical review of portfolio through Phase 2. Co-chair of Medical Plans Review Committee. Responsible for due diligence assessment prior to in-licensing of assets and technology for Lilly. Lead group of scientists with direct accountability for compliance, out-sourcing, academic collaborations, capital investment planning, competitive analysis, business process improvement, six sigma, and global research management. Lead business process integration efforts for strategic acquisitions and divestitures. Responsible for strategy and operations of Lilly Research Laboratories in Europe. Scientific advisor for Lilly venture investment.
  • Eli Lilly And Company
    Vice President Of Toxicology, Drug Dispositon, Pharmacokinetics And Lrl Europe
    Eli Lilly And Company Oct 2001 - 2007
    Indianapolis, Indiana, Us
    Senior leadership and oversight of the Toxicology and Drug Disposition Division. Recruited and hired scientists. Led discussion and scientific design of ADME studies for portfolio assets. Interfaced with senior research and development leadership to deliver Lilly's portfolio of innovation. Managed the global business and scientific support. Oversight of outsourcing pre-clinical studies to support development. Implemented a discovery support strategy in order to increase the technical probability of success of molecules in development. Leader of pre-clinical portfolio governance committee from Lead Phase to Phase 2.
  • Eli Lilly And Company
    Executive Director Of Toxicology And Drug Disposition Lilly Research Laboratories (Lrl) And Europe
    Eli Lilly And Company 1998 - Oct 2001
    Indianapolis, Indiana, Us
    Leader of scientific staff and strategic direction for Toxicology division. Led strategy and operational oversight of European research labs in England, Germany, Spain and Belgium.
  • Eli Lilly And Company
    Director, Drug Disposition And Biochemical Toxcology
    Eli Lilly And Company 1994 - 1998
    Indianapolis, Indiana, Us
    Division leader of ADME and pharmacokinetic group supporting Lilly research and development portfolio. Managed audited functions and reviewed regulatory submissions supporting label claims and new product approvals. Senior leader of Investigative Toxicology group responsible for understanding mechanisms of toxicity of compounds in development. Led a cross functional research and development team to redesign the project management support of teams prior transition to Phase 3 development.
  • Eli Lilly And Company
    Head, Biochemical Toxicology
    Eli Lilly And Company 1992 - 1994
    Indianapolis, Indiana, Us
    Leader of the Investigative Toxicology portion of the toxicology division.
  • Eli Lilly And Company
    Senior Pharmacologist
    Eli Lilly And Company 1990 - 1992
    Indianapolis, Indiana, Us
    Designed and conducted pre-clinical ADME studies on Alzheimer's research projects and principal ADME investigator for the candidate selection of Viracept, an HIV protease inhibitor which eventually benefitted patients. Worked on cross functional teams to deliver project goals.
  • Marion Merrel Dow
    Senior Research Chemist
    Marion Merrel Dow May 1989 - Oct 1990
    Clinical Drug Metabolism. Designed studies. Interpreted data. Created assays for clinical drug metabolism, distribution, absorption and elimination studies. Worked as drug metabolism representative to clinical development teams. Led a group of Research Scientists in comparative biotransformation studies.

Andrew M. Dahlem Skills

Biotechnology Pharmaceutical Industry Biopharmaceuticals Clinical Trials Oncology Life Sciences Lifesciences Toxicology Drug Discovery Drug Development Fda Pharmacokinetics Regulatory Submissions Regulatory Affairs Biomarkers Pharmacology Clinical Development Drug Metabolism Portfolio Management Pharmaceutics Technology Transfer Immunology Glp Clinical Research Biochemistry R&d Ind Medical Writing Gcp Therapeutic Areas Leadership Development Executive Management Neuroscience Validation Adme Analytical Chemistry Gmp Medical Affairs Diabetes Commercialization Hplc Vaccines Ctms Pharmacovigilance Protein Chemistry Pharmaceutical Optimization Neurology Sop 21 Cfr Part 11 Infectious Diseases

Andrew M. Dahlem Education Details

  • University Of Illinois Urbana-Champaign
    University Of Illinois Urbana-Champaign
    Drug Metabolism
  • The Ohio State University
    The Ohio State University
    Biology

Frequently Asked Questions about Andrew M. Dahlem

What company does Andrew M. Dahlem work for?

Andrew M. Dahlem works for Dr. Dahlem Consulting, Llc

What is Andrew M. Dahlem's role at the current company?

Andrew M. Dahlem's current role is President.

What is Andrew M. Dahlem's email address?

Andrew M. Dahlem's email address is da****@****lly.com

What is Andrew M. Dahlem's direct phone number?

Andrew M. Dahlem's direct phone number is +131760*****

What schools did Andrew M. Dahlem attend?

Andrew M. Dahlem attended University Of Illinois Urbana-Champaign, The Ohio State University.

What skills is Andrew M. Dahlem known for?

Andrew M. Dahlem has skills like Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Clinical Trials, Oncology, Life Sciences, Lifesciences, Toxicology, Drug Discovery, Drug Development, Fda, Pharmacokinetics.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.